Ron Ellis - Articles and news items

Merck logo
Merck logo

Exclusive worldwide agreement to develop and commercialize Phase III cancer candidate vintafolide (EC145)

Industry news, News / 16 April 2012 / Merck

Vintafolide is currently being evaluated in a Phase III clinical trial…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+